OMGA
Omega Therapeutics Inc

987
Mkt Cap
$166,100.00
Volume
0.00
52W High
$1.69
52W Low
$0.0002
PE Ratio
0.00
OMGA Fundamentals
Prev Close
$0.003
50D MA
$0.0347
Beta
-0.12
Avg. Volume
671,074.59
P/B
0.01
Loading...
Loading...
Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Omega Therapeutics Inc?
What is the 52-week high for Omega Therapeutics Inc?
What is the 52-week low for Omega Therapeutics Inc?
What was Omega Therapeutics Inc stock price yesterday?
What is the PE ratio of Omega Therapeutics Inc?
What is the Price-to-Book ratio of Omega Therapeutics Inc?
What is the 50-day moving average of Omega Therapeutics Inc?

Latest OMGA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.